Ferring Pharmaceuticals

Ferring Pharmaceuticals is a Swiss-based research-oriented pharmaceutical company that specialises in products in the field of Urology Oncology, Gastroenterology, Endocrinology and Reproductive Health.

At this meeting, Ferring Pharmaceuticals is featuring FIRMAGON^® (degarelix), a GnRH receptor antagonist. FIRMAGON^® is streamlined authority listed on the PBS for the treatment of locally advanced (equivalent to Stage C) or metastatic (equivalent to Stage D) carcinoma of the prostate

Visit the Ferring stand to learn more about FIRMAGON^® and its reconstitution and administration process.